Skip to main content
. 2013 Nov 22;3(11):e162. doi: 10.1038/bcj.2013.58

Table 2. Response to BVD therapy (n=70 evaluable).

Response After four cycles, n (%) Best response, n (%)
CR 11 (16) 14 (20)
VGPR 13 (18.5) 14 (20)
PR 26 (37) 26 (37)
SD 14 (20) 14 (20)
PD 6 (8.5) 2 (3)
At least PR 50 (71.5) 54 (77)

Abbreviations: BVD, bendamustine plus bortezomib and dexamethasone; CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; VGPR, very good partial response.